Children's Hospital Medical Center, Cincinnati Clinical Trials
Sponsors / Children's Hospital Medical Center, Cincinnati
Children's Hospital Medical Center, Cincinnati appears as lead sponsor on 660 trial records in ClinicalTrials.gov. The portfolio currently includes 108 recruiting studies, 49 active non-recruiting studies, and 419 completed studies. 48 trials in this portfolio were terminated or withdrawn before completion. The most common reasons cited for termination include slow or insufficient recruitment, funding constraints. Cumulative planned enrollment across all listed trials is 1,366,343 participants. These counts reflect the current state of the public ClinicalTrials.gov registry.
Termination reasons: Recruitment46% · Other27% · Funding8% · Efficacy6% · Safety4% · Regulatory4% · Business2% · PI/or_Site2%
Recent Terminations
- Chronic Graft Versus Host Disease"Study closed due to slow enrollment."
- NCT05699265 Stopped Apr 2025Fabry Disease"The sponsor withdrew funding since there was no progress with this study for a significant amount of time."
- Sickle Cell Disease"low accrual"
- Crohn Disease"This was the Pilot study. The larger, confirmatory study has started"
- Inflammatory Bowel Diseases"Principal Investigator resignation."
- Acute Kidney Injury"The device manufacturer has received a HDE for this population from the FDA"
- Allogeneic Hematopoietic Cell Transplantation"Post-transplant cyclophosphamide and abatacept can be used as standard-of-care approaches to GVHD prevention in the HLA mismatched donor-recipient setting and are simpler to use since study enrollment is not required."
- NCT04566965 Stopped Jun 2021Coronavirus"CARES and institutional funding ended"
- Allogeneic Hematopoietic Cell Transplantation"A new multisite study was opened in place of this study."
- Brain Tumors"The study was terminated as recommended by the DSMB due to inability to meet enrollment goals within the time frame allotted (target of 25 patients over 5 years)."
Active Trials (49 total)
- NCT01120353
- NCT07560007
- NCT05579639
- NCT06171217
- NCT04230356
- NCT05889624
- Atopic Dermatitis PHASE2NCT03742414
- Acute Myeloid Leukemia PHASE1/PHASE2NCT05580601
- NCT06960980
- XIAP Deficiency PHASE1NCT07433621
- NCT04908735
- Leukemia PHASE1NCT03826992
- NCT06131801
- NCT06863259
- Respiratory Disorders PHASE1/PHASE2NCT02272049
- ILD PHASE1/PHASE2NCT06012500
- ASD NANCT06670040
- NCT07217444
- NCT04857255
- NCT07409064